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INTRODUCTION
Ganoderma lucidum (GL; 靈芝 Ling Zhi) has been used exten‑
sively in traditional Chinese medicine in East Asia for years. Trit‑
erpenoids, bitter metabolites in the GL fruiting bodies and spores, 
exhibit many biological activities and pharmacological functions 
such as antihepatoma activity, antitumor activity, antioxidation 
activity, antihuman immunodeficiency virus activity, antiallergic 
activity, antihypertensive activity, hepatoprotection, and inhibition 
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ABSTRACT
The antihepatoma activity and liver protective function of the fermentation products (5 L fermenator) of Ganoderma lucidum 
(GL; 靈芝 Ling Zhi) cultivated in a medium containing black soybean (BS; 黑豆 Hēi Dòu) and Astragalus membranaceus (AM; 生
黃耆 Shēng Huáng Qí) at different fermentation temperatures were investigated in this study. Hep 3B cells pretreated with lovastatin 
were used to study the antihepatoma activity, and possible active components were analyzed by reverse‑phase high‑performance liquid 
chromatography. Carbon tetrachloride (CCl4)‑induced primary rat hepatocyte injury was further used to evaluate the liver protective 
activity of the fermentation products. While all the GL broth filtrates do not inhibit the growth of Hep 3B cells, the ethanolic extract 
from GL‑2 mycelia (GL‑2‑mE), cultivated in the medium containing BS (50 g/L) and AM (20 g/L) at 24°C for 11 days showed 
the best antihepatoma activity (IC50 26.6 μg/mL) than the other ethanolic extracts from GL mycelia, GL fruiting body, BS, and AM 
did. The antihepatoma activities were correlated with some unknown active components in these samples. Furthermore, GL‑2‑mE 
(100 μg/mL) without harmful effect on the growth of normal primary rat hepatocytes significantly maintained cell viability, reduced 
lactate dehydrogenase leakage, lowered lipid peroxidation, and increased glutathione peroxidase and glutathione S‑transferase activities 
in the CCl4‑induced damaged primary rat hepatocytes.
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of cholesterol synthesis and platelet aggregation.[1-3] The polysac‑
charides from GL fruiting bodies were also reported to possess 
antitumor, hypoglycemic, and immunomodulatory activities.[4,5] 
Black soybean (BS; 黑豆 Hēi Dòu), the seeds of Glycine max (L.) 
Merrill, containing isoflavones, anthocyanins, and soy protein was 
investigated for its carcinogenesis‑inhibitory, cholesterol‑lowering, 
antioxidation, and immunomodulatory effects.[6-9] The root of 
Astragalus membranaceus (AM; 生黃耆 Shēng Huáng Qí), a tra‑
ditional Chinese medicine, has many biological activities such as 
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immunomodulation, antiviral activity, antioxidation activity, cancer 
therapy, and prevention of cardiovascular diseases due to its active 
constituents, including polysaccharides, saponins, and flavonoids.
[10-14] It was reported that isoflavone glucosides are converted into 
isoflavone aglycones, which are easily absorbed from the small 
intestine, after the soybean extracts are cultivated with the GL 
mycelia for 15 days, and the mixture of isoflavone aglycones and 
polysaccharides have antiangiogenic activities in vivo.[15]
The liver is the major organ in humans for metabolism, detoxi‑
fication, and in the antioxidation system. Globally, hepatocellular 
carcinoma (HCC) is the most frequently occurring cancer and the 
leading cause of cancer death. Liver carcinogenesis is character‑
ized by multistep carcinogenesis. In addition to viral infection 
and environmental agents, including aflatoxin B1, smoking, and 
alcohol, recent studies identified several potential factors that may 
contribute to the pathogenesis of HCC, such as oxidative stress, 
chronic inflammation, and genetic diseases.[16] Carbon tetrachlo‑
ride (CCl4) is a hepatotoxin because it is metabolized in the liver 
by the cytochrome P450 oxidase system resulting in the produc‑
tion of reactive radicals that induce liver injury.[17,18] In addition, 
lovastatin, a 3-hydroxy-3-methylgutaryl-CoA reductase inhibitor, 
is used to clinically treat hypercholesterolemia, and it effectively 
arrests tumor cells in the G1 phase through the mevalonate/choles‑
terol pathway and p21/p27 induction.[19] Mevalonate‑demanding 
Hep 3B cells are more sensitive to growth arrest and apoptosis 
by a combination treatment with lovastatin and other anticancer 
agents, including taxol and Ganoderma triterpenoids.[1] Therefore, 
lovastatin-pretreated Hep 3B cells were used as the high-through‑
put antihepatoma screening system in this study.
In this study, we were interested in submerged fermentation of 
GL under various conditions, including in a medium containing BS 
and AM and at different temperatures, and interactions between 
GL and BS or AM were expected to produce fermentation prod‑
ucts with antihepatoma activity and liver protective function. The 
potential of a combination treatment with lovastatin and the GL 
fermentation products was evaluated, and possible active compo‑
nents in each sample were analyzed by performing reverse‑phase 
high-performance liquid chromatography (HPLC). Furthermore, 
we studied the effects of the fermentation products with the best 
antihepatoma activity on the antioxidation and detoxification sys‑
tems in normal and CCl4‑induced injured primary rat hepatocytes.
MATERIALS AND METHODS
Materials and preparation of samples
The GL (BCRC 36123) fermentation products were cultured 
at difference fermentation conditions as listed in [Table 1]. BS 
was purchased from Tainan County Hseija Fruit and Vegetable 
Transporting and Marketing Association (Tainan, Taiwan). AM 
was purchased from Microbio Co., Ltd. (Taipei, Taiwan). The fer‑
mentation product of GL fermentation was separated into broth (b) 
and mycelia (m). The broth was sterilized at 121°C for 30 min 
and then filtered through a 0.22-μm filter. The broth filtrates were 
lyophilized. The GL (BCBC 36123) fruiting body (GL-36123-fb) 
was obtained from Prof. Shean-Shong Tzean, Department of Plant 
Pathology and Microbiology, National Taiwan University (Taipei, 
Taiwan). One gram of dry mycelia or fruiting bodies of GL, BS, or 
AM was mixed with 95% ethanol (20 mL) and incubated at 30°C 
for 24 h with shaking. The ethanolic extracts were evaporated 
to dryness under vacuum. The yields of GL‑1‑mE, GL‑2‑mE, 
GL-3-mE, GL-4-mE, GL-36123-fbE, BSE, and AME were 23.2, 
22.8, 23.5, 8.3, 2.3, 21.3, and 10.6 g/100g dry matter, respectively.
Chemicals
Methanol (Tedia Co., OH, USA) and ethanol (95%) (Echo Co., 
Taipei, Taiwan) were used. Lovastatin was obtained from Wako 
Pure Chemical Industries Ltd. (Japan). Dulbecco’s modified Eagle 
medium (DMEM), antibiotic-antimycotic solution, MEM nones‑
sential amino acid solution, L‑15 medium, insulin, transferrin, fetal 
bovine serum (FBS), and penicillin‑streptomycin solution were 
purchased from Gibco Laboratories (Grand Island, NY, USA). Col‑
lagenase (type I) from Worthington Biochemical Co. (Lakewood, 
NJ, USA) and Percoll from Pharmacia LKB (Piscataway, NJ, USA) 
were used. N, N-dimethylfluoramide (DMF) was purchased from 
LabScan (Dublin, Ireland). We obtained bovine serum albumin 
(BSA), 1-chloro-2,4-dinitrobenzene (CDNB), collagen, dimethyl 
sulfoxide (DMSO), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet‑
razolium bromide (MTT), glutathione reductase (GRd), iodoacetic 
acid, N-[2-hydroxyethyl] piperazine-N′-[2-ethanesulfonic acid] 
(HEPES), oxidized glutathione (GSSG), phosphotungstic acid, 
reduced glutathione (GSH), β‑nicotinamide adenine dinucleo‑
tide (β-NADH), β‑nicotinamide adenine dinucleotide phosphate 
(β-NADPH), sodium azide (NaN3), silymarin, sodium dodecyl‑
sulfate (SDS), 1,1,3,3-tetraethoxypropane, 2-thiobarbituric acid, 
and trypsin-ethylenediaminetetraacetic acid (EDTA) solution from 
Sigma Chemical (St Louis, MO, USA).
Culture of hepatoma cells
Human hepatoma Hep 3B cells were kindly given by 
Dr. Shiao (Department of Life Science, Chang Gung University, 
Taoyuan, Taiwan). Cells were cultured in DMEM containing 
10% FBS, 100 units/mL penicillin, 100 μg/mL streptomycin, 
0.25 μg/mL amphotericin B, and 100 μM nonessential amino 
acids (pH 7.0) at 37°C in 5% CO2 and 90% relative humidity.
Antihepatoma activity assay
According to the methods of Shiao,[1] Hep 3B cells were cul‑
tured in 96‑well plates at a density of 5 × 103 cells/100 μL medium/
well. After 24 h of incubation, the medium in the 96‑well plate was 
replaced by 100 μL serum-free DMEM containing 0 or 10 μM lovas‑
tatin. After another 48 h of incubation, the medium was replaced by 
100 μL new serum-free DMEM containing various concentrations 
of the sample (the ethanolic extracts were previously dissolved in 
DMSO, and the final concentration of DMSO was 0.5%) for 48 h. 
Then the medium was discarded, and 25 μL MTT solution (5 mg/mL 
in phosphate-buffered saline [PBS]) and 100 μL serum-free DMEM 
were added to each well and reincubated for an additional 4 h. MTT 
lysis buffer (20 g SDS in 50 mL DMF and 50 mL water) (100 μL) 
was added to dissolve the formazan crystals formed. Then the plates 
were read at 570 nm in a microplate reader (Anthos 2001, Salzburg, 
Austria). Cells of the sample that were not exposed to lovastatin 
served as the control at 100% survival.
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Determination of major components by reverse‑phase 
HPLC
A model L‑7100 solvent‑delivery system (Hitachi, Tokyo, 
Japan) equipped with a model L‑2200 autosampler (Hitachi), 
a model L-7420 UV-VIS detector (Hitachi), and a Peak-ABC 
chromatography data handling system (JiTeng, Singapore) were 
used in the HPLC analysis. Separation was performed using a 
prepacked reverse‑phase column (Cosmoail 5C
18
, 25 × 0.46 cm 
I.D.; Nacalai Tesque, Kyoto, Japan). According to the method 
by Chyr and Shiao,[20] multi‑step linear‑gradient elution with a 
binary solvent system of methanol and water was employed, 
and a constant concentration of acetic acid (0.5%, v/v) was used. 
Ultraviolet detection at 243 nm was performed.
Isolation and culture of hepatocytes
Male Narl: SD rats (6-8 week old) were purchased from the 
National Laboratory Animal Center, Taipei, Taiwan. The rats were 
housed in plastic cages with an artificial 12-h light/dark cycle, and 
they were given food (Purina 5001 rodent chow diet, St. Louis, 
MO, USA) and water ad libitum. The method of hepatocyte isola‑
tion has been described.[21-23] Hepatocytes were plated at a density 
of 1 × 106 cells/2 mL in L-15 medium containing 18 mM HEPES, 
5 μg/mL insulin, 5 μg/mL transferrin, 1 mg/mL galactose, 1 mM 
dexamethasone, 100 units/mL penicillin, 100 mg/mL streptomycin, 
5 ng/mL Na2SeO3, and 0.2% BSA) in 35 mm collagen-precoated 
culture dishes (NUNC, Denmark) and incubated in a humidified 
incubator (NUAIRE, Plymouth, MN, USA) at 37°C in ambient 
atmosphere. The culture medium was replaced with fresh medium 
4 h after plating. The medium was changed using the same culture 
medium but containing 2 g/L BSA instead of FBS at 24 h after plating.
Treatment of hepatocytes
At 24 h after plating, hepatocytes (1 × 106) were treated with 
various concentrations of samples that were previously dissolved 
in DMSO (the final concentration of DMSO was 0.5%) for 24 h. 
In terms of CCl4‑induced injury in hepatocytes, cells (1 × 10
6) were 
coincubated with 10 mM CCl4, which was previously dissolved in 
99.5% ethanol (the final concentration of ethanol was <1%) and 
various concentrations of samples that were previously dissolved 
in DMSO (the final concentration of DMSO was 0.5%) for 1 h. The 
culture medium was removed after treatment, and the hepatocytes 
were washed with cold PBS. Then the cells were removed with a 
cell scraper and collected for further analysis.[24]
Lactate dehydrogenase leakage of hepatocytes
The effect of samples on the viability of primary hepatocytes was 
evaluated by lactate dehydrogenase (LDH) leakage.[25] After collect‑
ing the cell‑free medium, hepatocytes were lysed using 20 mM potas‑
sium phosphate buffer (1.090 g/L KH2PO4 and 2.090 g/L K2HPO4; 
pH 7.0) containing 0.5% Triton X‑100. Cells were collected and 
centrifuged at 10,000 × g for 30 min at 4°C. The supernatant was 
used to analyze the LDH activity. Samples were mixed in 1 mL of 
Krebs–Henseleit buffer (0.322 g/L CaCl2, 6.9 g/L NaCl, 0.36 g/L 
KCl, 0.13 g/L KH2PO4, 0.295 g/L MgSO4·7H2O, and 2 g/L NaHCO3; 
pH 7.4) containing 20 g/L BSA, 0.2 mM NADH, and 1.36 mM py‑
ruvate. The rate of change in absorbance at 340 nm due to NADH 
oxidation was recorded. Intracellular and extracellular LDH activi‑
ties were assayed, and the percentage of leakage was determined.
Lipid peroxidation
According to the method by Fraga, et al.,[26] thiobarbitu‑
ric acid-reactive substance (TBARS) level was measured to 
evaluate the condition of lipid peroxidation. The samples or 
standards (1,1,3,3-tetramethoxy propane) were mixed with 20 
mM potassium phosphate buffer, 3% SDS solution, 0.1 N hydro‑
chloric acid, 10% phosphotungstic acid, and 0.7% thiobarbituric 
acid (TBA), and then heated in boiling water for 30 min. The 
reactive products were extracted with n‑butanol and assayed 
with a fluorescence spectrophotometer at 515 nm excitation and 
555 nm emission. The results were compared with a standard curve 
expressed in nmole TBARS/mg protein.
Analysis of GSH and glutathione‑related enzymes
The GSH content in the hepatocytes was assayed as described 
by Reed, et al.[27] Samples were prepared by adding 1 mL of 
1 mol/L perchloric acid containing 2 mmol/L 1,10‑phenanthroline 
to each dish. The acid‑soluble GSH in the hepatocellular super‑
natant was measured by performing HPLC. Glutathione peroxi‑
dase (GPx) activity was assayed using hydrogen peroxide as the 
substrate.[28] According to the method by Bellomo, et al.,[29] GRd 
activity was assayed. Using CDNB as the substrate, glutathione 
S‑transferase (GST) activity was assayed by the method by Habig, 
et al.[30] Protein concentration of the samples was assayed accord‑
ing to the method by Lowry et al.[31]
Cell viability of hepatocytes using MTT assay
The hepatocytes were cultured in 96‑well collagen‑precoated 
plates at a density of 5 × 104 cells/100 μL of culture medium/well 
and incubated in a humidified incubator at 37°C in ambient air. The 
culture medium was replaced with fresh medium 4 h after plating. At 
24 h after plating, the hepatocytes were treated with 10 mM CCl4 and 
various concentrations of the samples. After 1 h treatment, the culture 
medium was removed, and the hepatocytes were washed with cold 
PBS. Then the cell viability was determined using the MTT assay.
Statistical analyses
Statistical analyses were performed using one‑way analysis of 
variance and Duncan’s multiple-comparison test (SAS Institute, 
Cary, NC, USA) to determine the significant differences among 
the mean values (P < 0.05).
RESULTS
Effect of fermentation products on hepatoma cells
The effects of GL broth filtrates and ethanolic extracts from 
GL mycelia on hepatoma Hep 3B cells pretreated with lovastatin 
are shown in [Figure 1]. Compared with the control, the cell 
viability of Hep 3B cells (the lovastatin-treated control) exposed 
to lovastatin for 48 h and then serum-free medium for another 
48 h was 80.6% of the control. In general, none of the GL broth 
filtrates at 100 μg/mL effectively inhibited the growth of Hep 3B 
cells. Silymarin as a positive control and the ethanolic extract 
from GL fruiting bodies (GL-36123-fbE) at 100 μg/mL exhib‑
Su, et al. / Journal of Traditional and Complementary Medicine 3 (2013) 110-118
113
ited good abilities to decrease cell viability by 67.5% and 93.9% 
of the control, respectively. GL-1, -2, and -3 were fermented 
in medium containing 50 g/L BS and 20 g/L AM at different 
temperatures [Table 1], and their ethanolic extracts (GL-1, -2, 
and -3-mE) at 100 μg/mL exhibited stronger antihepatoma ac‑
tivities resulting in <40% cell viability of the control compared 
with silymarin and GL-36123-fbE. Neither the broth filtrate nor 
the mycelia ethanolic extract from GL‑4, which was cultivated 
in a medium without BS or AM inhibited Hep 3B cell growth. 
The ethanolic extracts of BS (BSE) and AM (AME) at 100 μg/
mL did not significantly decrease the cell viability. It suggested 
that BS and AM improved the antihepatoma activities of the 
fermentation products after cultivating with BS and AM. Fur‑
thermore, the effects of the ethanolic extracts of GL mycelia 
with better antihepatoma activity at various concentrations on 
Hep 3B cells pretreated with lovastatin were investigated, and 
the result of each sample appeared to be dose dependent. The 
half maximal inhibitory concentration (IC50) values of silymarin 
and GL-36123-fbE were 51.8 and 41.6 μg/mL, respectively. 
GL‑2‑mE showed the lowest IC50 value (26.6 μg/mL) among 
the four fermentation products.
Determination of major components by reverse‑phase 
HPLC
The profiles of major components in the samples analyzed 
by reverse-phase HPLC are shown in [Figure 2]. The results 
showed that there were some compounds in GL‑1‑mE, GL‑2‑mE, 
GL-3-mE, and GL-4-mE, but not in GL-1-b, GL-2-b, GL-3-b, 
and GL-4-b. Total area of peaks 1-7 in the HPLC profile of 
GL-2-mE was larger than that of GL-1-mE, GL-3-mE, or 
GL-4-mE [Supplementary Table 1]. It also suggested that these 
compounds may be the major contributors to their antihepa‑
toma potentials on the basis of Pearson correlation coefficients 
[Supplementary Table 1]. As compared with the HPLC profiles 
of the ethanolic extracts of GL fermentation products, BS and 
AM might promote the formation of active components in the 
GL fermentation product since some major components cannot 
be detected in BSE and AME. In addition, the HPLC profiles 
are different between GL-36123-fbE and GL-2-mE. It sug‑
gested that different active compounds in the tested samples 
resulted in different antihepatoma effects, because the IC50 
values of GL-2-mE against Hep 3B cells was less than that of 
GL-36123-fbE [Figure 1].
Figure 1. Effects of broth filtrates and ethanolic extracts of Ganoderma lucidum (GL) mycelia on the growth of Hep 3B cells pretreated with lovastatin. 
*Sample codes: BS, black soybean; AM, Astragali membranaceus; b, broth filtrate; m, mycelia; fb, fruiting body; E, ethanolic extract. Hep 3B cells 
pretreated with lovastatin for 48 h were treated with samples for another 48 h (n = 3). Cell viability was determined by MTT assay. Values bearing 
different letter are significantly different (P < 0.05)
Table 1. Fermentation conditions of Ganoderma lucidum fermentation products produced using black soybean and Astragalus membranaceus as part of 
the liquid fermentation medium
Samplea Fermentation conditions
BS (g/L) AM (g/L) Temperature (°C) Agitation (rpm) Aeration  (vvm) Initial pH Fermentation time 
(day)
Final mycelia yield 
(g/100 mL)
GL‑1 50 20 18 50 0.75 6.0 11 0.565
GL‑2 50 20 24 50 0.75 6.0 11 0.793
GL-3 50 20 30 50 0.75 6.0 11 2.212
GL‑4 ‑ ‑ 18 100 1.25 3.5 11 0.342
aAll products were fermented by Ganoderma lucidum (BCRC 36123), The fermentation medium contains 2% glucose in a 5 L fermentor
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Figure 2. HPLC chromatograms of major components in GL-1-b (a), GL-1-mE (b), GL-2-b (c), GL-2-mE (d), GL-3-b (e), GL-3-mE (f), GL-4-b (g), 
GL-4-mE (h), BSE (i), AME (j), and GL-fbE (k). *Sample code: GL, Ganoderma lucidum; BS, black soybean; AM, Astragali membranaceus; b, broth 
filtrate; m, mycelia; fb, fruiting body; E, ethanolic extract. The concentration of each sample was 20,000 μg/mL. The retention time of peak 1 is 
15.2 min, peak 2 is 22.0 min, peak 3 is 22.6 min, peak 4 is 26.1 min, peak 5 is 27.5 min, peak 6 is 28.3 min, and peak 7 is 52.1 min
Supplementary Table 1. Correlation of antihepatoma activity and major components existing in broth filtrates and mycelia ethanolic extracts of 
Ganoderma lucidum
Sample Cell viability 
(% of control)a,b
Peak area
Peak no. 1 2 3 4 5 6 7 Total
GL‑1‑b 95.2±13.0 ‑ ‑ ‑ ‑ ‑ ‑ ‑ 0
GL‑1‑mE 37.3±8.4 2608106 115952 40871 2327070 121584 84379 205822 5503784
GL‑2‑b 86.7±3.9 ‑ ‑ ‑ ‑ ‑ ‑ ‑ 0
GL‑2‑mE 28.0±11.2 6655128 46566 50452 2693210 320514 271155 174290 10211315
GL-3-b 96.9±6.2 ‑ ‑ ‑ ‑ ‑ ‑ ‑ 0
GL-3-mE 36.4±14.8 4306776 53073 117334 2970378 438309 419871 176825 8482566
GL‑4‑b 81.0±9.7 ‑ ‑ ‑ ‑ ‑ ‑ ‑ 0
GL‑4‑mE 133.4±12.6 533467 ‑ ‑ 106737 ‑ ‑ 364219 1004423
Pearson correlation coefficientsc −0.8173 −0.7972 −0.8173 −0.8891 −0.7972 -0.7578 −0.0260 −0.7578
P value 0.0132 0.0178 0.0132 0.0031 0.0178 0.0294 0.9513 0.0294
aEffect of broth filtrates (b) and mycelia ethanolic extracts (mE) of G. lucidum (GL) (100 μg/mL) on the growth of Hep 3B cells pretreated with lovastatin. 
Cell viability was determined by MTT assay, bEach data represents mean±SD (n=3), cThe peak areas were of higher negative correlation with cell viabilities 
indicated that the compounds might be of the major components for contributing antihepatoma activity
Effect of GL‑2‑mE on normal primary rat hepatocytes
After treatment with 50, 100, or 200 μg/mL of GL‑2‑mE for 24 h, 
the results of LDL leakage, lipid peroxidation (TBARS production), 
GSH content, and GSH‑related enzyme activities in normal primary 
rat hepatocytes are shown in Table 2. It indicated that DMSO (0.5%) 
and GL‑2‑mE (<200 μg/mL) did not significantly affect the hepa‑
tocytes on the basis of the LDL leakage compared with the control, 
but GL‑2‑mE at 100 μg/mL tended to decrease more TBARS value 
and increase higher GSH level and GPx activity compared with the 
control (DMSO) than those of 200 μg/mL treatment. It also suggested 
that GL‑2‑mE possessed the capability of cytotoxic selectivity toward 
hepatoma cells rather than normal primary rat hepatocytes.
Effect of GL‑2‑mE on primary rat hepatocytes 
damaged by CCl4
To study the liver protective activity of GL‑2‑mE, CCl4 was 
further used to induce primary rat hepatocytes injury ex vivo 
[Figure 3 and Table 3]. DMSO (0.5%) and ethanol (1%) helped 
GL‑2‑mE and CCl4 to dissolve in the medium, respectively, and 
they did not significantly affect normal primary rat hepatocytes, in‑
cluding morphology [Figure 3a and b], LDH leakage, cell viability, 
TBARS value, and GSH level [Table 3], or the activities of GPx, 
GRd, and GST [Table 3]. The results of morphological observa‑
tions also indicated that CCl4 could induce primary rat hepatocyte 
damage, including shrinkage, rupture, and death, compared with 
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the control (DMSO + ethanol) [Figure 3a-c]. Both silymarin and 
GL‑2‑mE at 100 μg/mL can prevent the hepatocytes from being 
damaged by CCl4 on the basis of the morphology [Figure 3f and i].
Carbon tetrachloride increased LDH leakage and decreased the 
cell viability, which were complicated by increased TBARS values 
and reduced GSH levels in primary rat hepatocytes [Table 3]. Sily‑
marin at 1 μg/mL reduced 36% of LDH leakage and increased cell vi‑
ability by 22%, which were significantly changed by CCl4 (P < 0.05), 
and even 100 μg/mL silymarin caused recovery of LDH leakage and 
cell viability to a normal condition and maintained the TBARS and 
GSH levels similar to those of the control. GL‑2‑mE at 10 and 100 
μg/mL also decreased the LDH leakage increased by CCl4 and main‑
tained significantly more living hepatocytes (P < 0.05). GL‑2‑mE at 
100 μg/mL significantly reduced TBARS values by 46% (P < 0.05) 
and slightly elevated the GSH level.
Furthermore, GPx, GRd, and GST activities in primary rat he‑
patocytes treated with CCl4 and samples were detected [Table 3]. 
The results showed that CCl4 treatment significantly decreased the 
activities of all the three enzymes (P < 0.05). Silymarin at 100 μg/mL 
significantly elevated GPx activity to 46 nmol/min/mg protein com‑
pared with CCl4 treatment (P < 0.05), and GL‑2‑mE at 100 μg/mL 
significantly increased GPx and GST activities to 39 and 102 nmol/
min/mg compared with CCl4 treatment, respectively (P < 0.05).
DISCUSSION
Because cultivating GL fruiting bodies might take several 
months, and it is also difficult to control the quality, we were 
interested in submerged fermentation to produce fungal products 
with biological activity. Some investigations referred that differ‑
ent initial pH values or inoculation densities result in different 
productions of extracellular and intracellular polysaccharides 
or ganoderic acids in a fed batch fermentation of GL.[32,33] In the 
present study, we examined the antihepatoma activities of four 
GL fermentation products produced under different fermentation 
conditions, including medium with or without BS and AM and 
various fermentation temperatures.
Hep 3B cells pretreated with lovastain, a clinical hypercholes‑
terolemic drug, was used to evaluate the antihepatoma potentials 
of GL fermentation products. It was reported that taxol or trit‑
erpenoids form Ganoderma tsugae more effectively inhibit the 
growth of lovastatin-pretreated Hep 3B cells.[1] It also suggested 
that Hep 3B cells pretreated with lovastatin are generally more 
sensitive to ethanolic extracts of mycelia than to broth filtrates, and 
GL-1, -2, and -3-mE have stronger inhibitive abilities than silyma‑
rin according to their IC50 values [Figure 1]. The GL fermentation 
product (GL‑2) with the best antihepatoma activity was cultivated 
Table 3. Effect of the ethanolic extract of GL mycelia (GL-2-mE) on lactate dehydrogenase (LDH) leakage, cell viability, thiobarbituric 
acid-reactive species (TBARS) and glutathione (GSH), and glutathione peroxidase (GPx), glutathione reductase (GRd) and glutathione 
S‑transferase (GST) activities levels in primary rat hepatocytes damaged by carbon tetrachloridea, b
Group Dose 
(μg/mL)
LDH 
leakage (%)
Cell 
viability (%)
TBARS 
(nmol/mg protein)
GSH 
(nmol/mg protein)
GPx GRd GST
nmol/min/mg protein
Control 4.6±2.1* 100.0±4.9* 0.55±0.11* 91.0±16.7* 159±26* 44.5±6.6* 551±35*
Control 
(DMSO+ethanol)
4.0±1.7* 97.9±5.0* 0.52±0.15* 92.2±13.3* 145±11* 41.0±3.6 535±41*
CCl4 60.0±20.4 36.4±12.1 1.14±0.26 41.5±13.4 108±12 30.4±3.6 356±38
CCl4+silymarin 1 24.5±2.2* 58.5±21.4 1.08±0.30 56.0±15.2 102±31 31.9±6.0 342±41
10 9.5±3.2* 73.6±15.2* 0.95±0.28 64.0±24.0 130±12 37.0±5.1 435±92
100 3.3±1.9* 101.8±18.9* 0.59±0.10* 95.5±16.5* 154±15* 38.6±5.5 441±71
CCl4+GL-2-mE 1 51.3±16.2 57.7±24.4 1.02±0.11 66.0±19.2 100±29 29.3±7.0 322±45
10 18.3±1.5* 68.0±20.8* 0.97±0.20 69.6±19.7 136±22 39.7±11.1 424±43
100 11.2±3.8* 80.9±4.7* 0.61±0.13* 74.8±23.6 147±13* 41.3±10.7 458±43*
aHepatocytes were isolated from 6 to 8 week-old male rats. Hepatocytes isolated from each animal were divided equally and cultured in medium containing 
10 mM CCl4 and various concentrations of GL-2-mE for 1 h. Values are expressed as the mean±SD from 3 or 4 rats. 
b*represents that the data is significant 
different (P<0.05) when compared with the CCl4 treatment group.
Table 2. Effect of the ethanolic extract of GL mycelia (GL-2-mE) on lactate dehydrogenase (LDH) leakage, thiobarbituric acid-reactive 
species (TBARS) and glutathione (GSH) levels, and glutathione peroxidase (GPx), glutathione reductase (GRd) and glutathione 
S‑transferase (GST) activities in normal primary rat hepatocytesa,b
Group Dose 
(μg/mL)
LDH 
leakage (%)
TBARS 
(nmol/mg protein)
GSH 
(nmol/mg protein)
GPx GRd GST
nmol/min/mg protein
Control 0.8±0.8 0.53±0.07 85.4±15.7 160±17 55.3±8.2 580±75
Control (DMSO) 1.8±1.4 0.51±0.13 69.4±10.6 162±16 62.1±4.3 657±108
GL‑2‑mE 50 2.3±1.9 0.50±0.06 89.2±8.4 161±27 58.3±9.0 580±86
100 2.0±1.4 0.44±0.05 88.0±2.3 181±33 60.7±13.0 620±41
200 3.4±3.0 0.46±0.05 85.7±15.6 169±29 59.6±10.7 596±41
aHepatocytes were isolated from 6 to 8 week-old male rats. Hepatocytes isolated from each animal were divided equally and cultured in medium containing 
various concentrations of GL-2-mE for 24 h. Values are expressed as mean±SD from 3 or 4 rats. bResults were not significantly different according to 
Duncan’s multiple range test (P<0.05)
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in a medium containing 50 g/L BS and 20 g/L AM at 24°C for 
11 days, and it suggested that the main contributing constituents 
in the ethanolic extract of GL mycelia might be affected by fer‑
mentation temperature, fermentation medium composition, culture 
method, GL species, etc., [Figure 2]. In our study, the amounts of 
major components were not enough to identify their structures, 
but the HPLC results suggested that variable active compounds 
in the fermentation products and fruiting body resulted in lower 
IC50 values of GL-2-mE against Hep 3B cells compared with 
GL-36123-fbE [Figure 1]. It indeed has been reported that differ‑
ent triterpenoids isolated form GL fruiting body and fermentation 
products have different anticancer abilities.[34-36] Additionally, 
except for triterpenoids, other ingredients with antihepatoma ac‑
tivity might exist in the ethanolic extracts from GL fermentation 
products and need to be further confirmed; for example, ergosterol 
derivatives and long chain fatty acids.[37,38]
BSE, AME, and GL‑4‑mE, which were cultivated without 
BS or AM at 100 μg/mL could not inhibit the growth of Hep 3B 
cells, but BS and AM improved the antihepatoma activities of the 
fermentation products (GL-1, -2, and -3) after cultivation with 
BS and AM [Figure 1]. In our previous study, we also found that 
BS modified the antihepatoma activity of Agaricus blazei against 
Hep 3B and Hep G2 cells because it promoted the production 
of the active compounds.[39] It was reported that β‑glucosidase 
from GL mycelia converted isoflavone glucosides into isoflavone 
aglycones when soybean extracts were cultivated with GL.[15] 
Therefore, we speculated that GL might convert the inactive 
components in BS or AM into active ones during the fermenta‑
tion process in the present study. In addition, the formations of 
major components in GL fermentation products might be derived 
from the BS or AM. For example, soybean contains fatty acids, 
squalene, and phytosterol,[40] which could be the starting materials 
to biosynthesize active compounds such as cytotoxic steroids in 
A. blazei fermentation products.[41,42] In contrast, BS and AM might 
promote the production of active secondary metabolites in the GL 
fermentation products. Other components existing in BS or AM 
could also affect enzymatic activities for the biosynthesis of the 
major components, including trace elements, phenolic compounds, 
isoflavones, anthocyanins, saponins, etc.[43-48] Therefore, our study 
will be as an interesting reference for future investigators to study 
the change of the active compounds in the fungi fermentation 
products cultivated in a medium containing BS and AM.
The triterpene‑enriched fraction, which was prepared from GL 
mycelia, inhibited the growth of human hepatoma Huh‑7 cells, 
but not normal human Chang liver cells.[36] In order to evaluate 
the hepatoxicity of GL fermentation product with antihepatoma 
activity in this study, normal primary rat hepatocytes were treated 
with various concentrations of GL‑2‑mE, which exhibited the best 
inhibitive ability against Hep 3B cells. GL-2-mE (<200 μg/mL) 
caused no significant harmful influence on the hepatocytes, but at 
100 μg/mL slightly increased GSH level and GPx activity resulted 
in lower lipid peroxidation compared with the control (DMSO) 
after 48 h treatment [Table 2]. Furthermore, CCl4 is metabolized 
by the cytochrome P450 oxidase system resulting in reactive 
radicals that induce lipid peroxidation and reduce the content of 
reduced GSH and the activities of GSH‑related enzymes in the 
liver.[17,18] Therefore, liver protective function of GL‑2‑mE was 
further evaluated using CCl4‑induced primary rat hepatocyte injury. 
Figure 3. Effect of GL‑2‑mE on the morphology of primary rat hepatocytes damaged by CCl4. *Hepatocytes were treated with 10 mM CCl4 and various 
concentrations of samples for 1 h. a ~ i show the control, the control (DMSO + ethanol), CCl4, CCl4 + silymarin (1 μg/mL), CCl4 + silymarin (10 μg/mL), 
CCl4 + silymarin (100 μg/mL), CCl4 + GL‑2‑mE (1 μg/mL), CCl4 + GL‑2‑mE (10 μg/mL), and CCl4 + GL‑2‑mE (100 μg/mL), respectively. Silymarin 
was the positive control. 100 × under an inverted-stage microscope equipped with phase contrast. “—”: 50 μm
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Both triterpenoids and polysaccharides from the hot‑water extract 
of GL fruiting bodies can inhibit lipid peroxidation in erythrocyte 
cell membranes and liver mitochondria.[3] Ganoderic acids were 
also reported to retard CCl4‑induced liver damage in mice.
[49] 
In our study, the cell viability of primary rat hepatocytes with 
CCl4‑induced injury were recovered after treatment with 100 μg/
mL GL-2-mE, because it improved the GPx and GST activities, 
lowered lipid peroxidation, and reduced LDH leakage [Table 3]. It 
suggested that there might be some components with antioxidant 
activity or novel ability to regulate glutathione‑related enzyme 
activities in GL‑2‑mE to protect primary hepatocytes from 
CCl4‑derived radicals.
In conclusion, this is the first study using BS and AM to cultivate 
GL in 5 L fermentation system with different fermentation tempera‑
tures to produce fermentation products with antihepatoma activity 
and liver protective effect. The ethanolic extract of GL fermentation 
mycelia (GL‑2‑mE) cultivated in medium containing BS (50 g/L) 
and AM (20 g/L) at 24°C for 11 days exhibited better antihepatoma 
activity than the ethanolic extract of GL-36123 fruiting body be‑
cause of the difference in possible active components. GL‑2‑mE 
(<200 μg/mL) did not cause any damage in normal primary rat he‑
patocytes, whereas it at 100 μg/mL obviously prevented hepatocytes 
from CCl4‑induced injury. Further investigation of the constituents 
in the GL fermentation products with different fermentation condi‑
tions is needed to clarify the contributors to and mechanisms of the 
biological activities. These results provide important information 
for the development of health food for human beings.
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